Use of Corticosteroid in Persistent Post-COVID-19 Interstitial Lung Disease.

Khaw, Chuen R; Richardson, Charlotte; Bhowmik, Angshu; Agbetile, Joshua; Rajakulasingam, Raja K

Khaw, Chuen R; Richardson, Charlotte; Bhowmik, Angshu; Agbetile, Joshua; Rajakulasingam, Raja K.

Khaw CR; Homerton University Hospital NHS Foundation Trust London, United Kingdom.
Richardson C; Homerton University Hospital NHS Foundation Trust London, United Kingdom.
Bhowmik A; Homerton University Hospital NHS Foundation Trust London, United Kingdom.
Agbetile J; Homerton University Hospital NHS Foundation Trust London, United Kingdom.
Rajakulasingam RK; Homerton University Hospital NHS Foundation Trust London, United Kingdom.

Ann Am Thorac Soc ; 18(9): 1599, 2021 09.

Article in English | MEDLINE | ID: covidwho-1288697

Subject(s)

COVID-19; Lung Diseases, Interstitial; Adrenal Cortex Hormones; Humans; Lung Diseases, Interstitial/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lung Diseases, Interstitial / COVID-19 Topics: Long Covid Limits: Humans Language: English Journal: Ann Am Thorac Soc Year: 2021 Document Type: Article Affiliation country: AnnalsATS.202105-623LE

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google